Literature DB >> 24360642

Hospital and provider patient volumes, cesarean section rates, and early postpartum invasive methicillin-resistant Staphylococcus aureus infection.

Andrea M Parriott1, Joelle M Brown2, Onyebuchi A Arah3.   

Abstract

OBJECTIVE: We sought to examine whether hospital and provider volumes and cesarean section rates influenced early postpartum invasive methicillin-resistant Staphylococcus aureus (MRSA) infection.
METHODS: We used data from the Nationwide Inpatient Sample, a representative sample of US community hospitals. Multivariate hierarchical regression models were used to estimate odds ratios adjusted for hospital total discharges, nurse:patient ratio, urbanicity, teaching status, bed size, ownership, and geographic region and patient age, race, expected payer, and comorbidities.
RESULTS: The total sample size for the hospital analysis was 3,487,350 deliveries, which included 555 cases of MRSA infection. The total sample size for the provider analysis was 1,186,703 deliveries, with 221 cases of MRSA infection. Hospital and provider patient (deliveries) volumes and cesarean section rates were not associated with early postpartum invasive MRSA infection.
CONCLUSIONS: Barring major bias in our estimates, our results suggest that transmission from providers may not be a predominant route of postpartum MRSA infection in US hospitals.
Copyright © 2014 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  Drug resistance; Hospital statistics; Numerical data; Obstetrics; Puerperal infection; Staphylococcal infections

Mesh:

Year:  2013        PMID: 24360642      PMCID: PMC5600614          DOI: 10.1016/j.ajic.2013.08.003

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  15 in total

1.  Commentary: Does patient volume matter for low-risk deliveries?

Authors:  Ciaran S Phibbs
Journal:  Int J Epidemiol       Date:  2002-10       Impact factor: 7.196

Review 2.  Different classes of antibiotics given to women routinely for preventing infection at caesarean section.

Authors:  Zarko Alfirevic; Gillian Ml Gyte; Lixia Dou
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

3.  Committee opinion no. 465: antimicrobial prophylaxis for cesarean delivery: timing of administration.

Authors: 
Journal:  Obstet Gynecol       Date:  2010-09       Impact factor: 7.661

4.  Maternal outcomes associated with planned primary cesarean births compared with planned vaginal births.

Authors:  Eugene Declercq; Mary Barger; Howard J Cabral; Stephen R Evans; Milton Kotelchuck; Carol Simon; Judith Weiss; Linda J Heffner
Journal:  Obstet Gynecol       Date:  2007-03       Impact factor: 7.661

Review 5.  Increasing occurrence of methicillin-resistant Staphylococcus aureus in the United States.

Authors:  J M Boyce; W A Causey
Journal:  Infect Control       Date:  1982 Sep-Oct

6.  Interhospital differences in nosocomial infection rates: importance of case-mix adjustment.

Authors:  Hugo Sax; Didier Pittet
Journal:  Arch Intern Med       Date:  2002-11-25

Review 7.  Maternal sepsis: epidemiology, etiology and outcome.

Authors:  Jeroen van Dillen; Joost Zwart; Joke Schutte; Jos van Roosmalen
Journal:  Curr Opin Infect Dis       Date:  2010-06       Impact factor: 4.915

Review 8.  Current debate on the use of antibiotic prophylaxis for caesarean section.

Authors:  R F Lamont; J D Sobel; J P Kusanovic; E Vaisbuch; S Mazaki-Tovi; S K Kim; N Uldbjerg; R Romero
Journal:  BJOG       Date:  2011-01       Impact factor: 6.531

9.  Representativeness of the surveillance data in the intensive care unit component of the German nosocomial infections surveillance system.

Authors:  Irina Zuschneid; Gerta Rücker; Rotraut Schoop; Jan Beyersmann; Martin Schumacher; Christine Geffers; Henning Rüden; Petra Gastmeier
Journal:  Infect Control Hosp Epidemiol       Date:  2010-09       Impact factor: 3.254

10.  The association between hospital obstetric volume and perinatal outcomes in California.

Authors:  Jonathan M Snowden; Yvonne W Cheng; Caitlin P Kontgis; Aaron B Caughey
Journal:  Am J Obstet Gynecol       Date:  2012-10-01       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.